Skip to content
Parakho

Asarfi Hospital Ltd

BSE 543943asarfihospital.com

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Q4 FY26

Asarfi Hospital reported consolidated FY26 revenue growth of 42% year-on-year to INR173.5 crores, with EBITDA up 42% to INR35.3 crores and PAT up 58% to INR16.7 crores. Q4 FY26 consolidated revenue grew 29% year-on-year to INR45.2 crores, with EBITDA of INR7.7 crores and PAT of INR3.9 crores. Management discussed capacity expansion in cardiology and cancer care, delays in bone marrow transplant approval and a proposed hospital merger, and outlined a Vision 2028 target of INR400 crores revenue with 500-plus beds.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 24 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.